
Trading floor: Dimerix biotech up, Healthco REIT soars
Dimerix moves higher on Japan trial Shares in Melbourne-based Dimerix (ASX: DXB) were up around 3% at the open after the small-cap biotech stock revealed its first clinical trial site in Japan for the Phase 3 ACTION3 study of DMX-200, targeting FSGS (a …